Ingenuity Announces Licensing of Both Ingenuity Pathways Knowledge Base and IPA to the Serono Genetics Institute (SGI)

SGI WILL USE INGENUITY PRODUCTS FOR GENOMICS RESEARCH AND FOR DEVELOPING INTERNAL TOOLS FOR RESEARCH SCIENTISTS

Mountain View, CA – June 14, 2005 – Ingenuity announced today the upcoming release of its flagship product, IPA.

Ingenuity announced today that Serono Genetics Institute has licensed its Pathways Knowledge Base for use in developing state-of-the-art internal drug discovery and development tools. The Ingenuity Pathways Knowledge Base is the world’s largest manually curated biological database created from millions of individually modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.

Serono also licensed IPA, an application that allows scientists to simultaneously analyze multiple genomic and proteomic datasets to rapidly gain biological insights. Ingenuity’s newest release, announced March 15, 2005, now includes Sharing and Workgroups. The new functionality facilitates the communication of analysis results between colleagues in research organizations.

About Ingenuity Systems

Ingenuity Systems is helping life science researchers explore and understand biological systems that are foundational to human health and disease. Ingenuity delivers capabilities and expertise to researchers through analysis software, genome-scale computable network databases, and knowledge management services and infrastructure, resulting in increased productivity and faster drugs to market. The company was founded in 1998 and is headquartered in Mountain View, California.www.ingenuity.com.